3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Oropharyngeal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Anus Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anal Canal Carcinoma
1
Interventions
Temozolomide
18
Radiation
7
Magnetic Resonance Spectroscopy
7
Radiotherapy
6
Specimen Handling
4
Lomustine
4
Bevacizumab
4
Aminolevulinic Acid
3
veliparib
2
trametinib
2
lutetium Lu 177 dotatate
2
dabrafenib
2
azeliragon
2
Surgical Procedures, Operative
2
Receptors, Interleukin-8B
2
Nivolumab
2
D2C7-(scdsFv)-PE38KDEL
2
Carboplatin
2
Biopsy
2
varlilumab
1
ulixertinib
1
tinostamustine
1
selinexor
1
ruxolitinib
1
ribociclib
1
relatlimab
1
regorafenib
1
peposertib
1
pembrolizumab
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Watchful Waiting
×
30 days
×
Clear all
No trials found.